Navigation Links
Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
Date:11/16/2011

AMSTERDAM, November 17, 2011 /PRNewswire/ --

Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, today provided its non-audited business update in compliance with the EU transparency directive. This report summarizes material events and AMT's financial position for the third quarter of 2011.

3Q 2011 Highlights

  • Glybera® Marketing Authorisation Application filed for re-examination
  • Exclusive license signed with National Institutes of Health (NIH) for use of adeno-associated virus serotype 5 (AAV5)-based gene therapy vectors for liver and brain indications
  • Dr. Carlos R. Camozzi appointed as Chief Medical Officer

CHMP Decision on Glybera and Re-organization

  • Glybera Marketing Authorisation Application re-examination:
    • Committee for Advanced Therapies (CAT), Scientific Advisory Group (SAG) and new Rapporteur/Co-Rapporteur all recommended Glybera approvable under exceptional circumstances
    • CHMP concluded that there are no significant safety issues with Glybera
    • CHMP concluded that insufficient evidence of clinical benefit means Glybera is not approvable at this time
  • AMT will focus development efforts and financial resources on three gene therapy programs: hemophilia B, GDNF and acute intermittent porphyria
  • Company remains committed to participating in the Sanfilippo B program, which is fully funded by a consortium led by Institut Pasteur
  • Further investment in and development of Glybera and Duchenne's muscular dystrophy programs suspended
  • AMT management is working in close consultation with the AMT Works Council to assess the impact of the review on the Company's workforce
  • Management and board believe that for AMT to remain a viable business it needs to reduce the headcou
    '/>"/>

SOURCE Amsterdam Molecular Therapeutics (AMT) B.V
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
2. Amsterdam Molecular Therapeutics Reports Full Year Results 2008
3. Amsterdam Molecular Therapeutics Reports Half Year Results 2009
4. The University of Amsterdam Joins the MetaMiner Metabolic Diseases Project
5. Amsterdam Molecular Therapeutics Reports Full Year Results 2009
6. Amsterdam Molecular Therapeutics Reports Half-Year Results 2010
7. Amsterdam Molecular Therapeutics Successfully Lowers Cholesterol In Vivo With Enhanced Novel MicroRNA AAV Gene Therapy
8. Amsterdam Molecular Therapeutics Appoints Dr. Carlos R. Camozzi as Chief Medical Officer
9. Amsterdam Molecular Therapeutics Files Glybera® European Marketing Application for Re-examination
10. Amsterdam Molecular Therapeutics Reports Half-Year Results 2011
11. Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... the device," Nobel laureate Herbert Kroemer famously ... be found at the junctures where layers ... world of nanotechnology, the interfaces between layers ... with applications in such high-tech favorites as ... the vast potential of these metal oxide ...
(Date:1/15/2014)... NIAGARA FALLS, N.Y., Jan. 15, 2014 /PRNewswire/ ... announce that it has been selected by Buffalo ... component supplier in support of its SBIR Phase ... B3 has developed the only comprehensive air purification ... VOCs and other chemical pollutants, allergens and organic ...
(Date:1/15/2014)... SAN JOSE, California , January 15, 2014 /PRNewswire/ ... developing antibody-drug conjugates for cancer, today announced the appointment ... of Directors. Dr Reynolds has over 20 years, development ... Chief Medical Officer at Seattle Genetics. "I ... for Oxford BioTherapeutics, as the company completes its transition ...
(Date:1/15/2014)... 15, 2014 A study has ... races on the Formula 1 track could help to ... between McLaren Applied Technologies (MAT), Stowhealth (a GP surgery ... is being funded by healthcare provider Simplyhealth. ... collect data about the on-track performance of Vodafone McLaren ...
Breaking Biology Technology:A deeper look at interfaces 2Niagara Thermal Products LLC Selected as Critical Supplier for Buffalo BioBlower Air Purification Systems 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4
... HOUSTON, Jan. 7 Cyberonics, Inc. (Nasdaq: CYBX ... the U.S. Food and Drug Administration ("FDA") to amend the ... treated with VNS TherapyTM.Based on a reassessment of the study ... to the data analysis originally specified in the study protocol, ...
... ALTO, Calif., Jan. 7 Intradigm Corporation, a ... today,announced that the company has closed the final ... led the $2.9 million tranche, with,existing investor, Lilly ... brings the total Series B financing to $21.4 ...
... TAMPA BAY, Fla., Jan. 7 News briefs concerning economic,and ... Bay Partnership: , Draper Labs Acquires ... The Charles Stark Draper Laboratory bought a 41,000-square-foot building,in St. ... Renovations to the building, 10050 16th St. N., should ...
Cached Biology Technology:Cyberonics Provides Business Update on Depression Clinical Trial 2Cyberonics Provides Business Update on Depression Clinical Trial 3Intradigm Closes Final Tranche of $21.4 Million Series B Financing 2Intradigm Closes Final Tranche of $21.4 Million Series B Financing 3Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 2Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 3Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs) 4
(Date:4/15/2014)... ITHACA, N.Y. If an insect drew a line ... would be a tangled mess. But there,s method to ... of mechanical engineering and physics, who tries to find ... Photo: https://cornell.box.com/tbeetle , It turns out the ... an optimal reorientation dance as it chases its prey ...
(Date:4/15/2014)... the loveliest in the world, but they also contain ... have become enriched in cadmium. Grasses take up this ... cattle and sheep that graze them. The problem is ... worldwide. , The concern is that if cadmium concentrations ... human health and New Zealand,s agricultural economy could be ...
(Date:4/15/2014)... world for which no pharmaceutical treatment exists. These include, ... in the tropics, as well as a type of ... easily spread by the hands and can be dangerous ... at Aalto University and the University of Eastern Finland ... spread of one type of virus into cells with ...
Breaking Biology News(10 mins):Photo: Tiger beetle's chase highlights mechanical law 2Nanocrystalline cellulose modified into an efficient viral inhibitor 2
... 2008 -- In a move that promises to change the ... unveiled a set of techniques for cleanly converting problematic biofuels ... research is available online in the journal Metabolic Engineering ... describe a new fermentation process that allows E. coli ...
... Southern Research Station (SRS) today announced that an SRS ... responsible for killing redbay and other trees in the ... Lead author and Iowa State University ... Stephen Fraedrich, and Azerbaijan National Academy of Sciences Researcher ...
... IMMEDIATE RELEASE The tummy,s taste for red wine ... Chemistry What happens when red wine meets red ... Israel are reporting, wine,s bounty of healthful chemical compounds may ... in the meat. The study, which reinforces the benefits of ...
Cached Biology News:Research yields pricey chemicals from biodiesel waste 2Research yields pricey chemicals from biodiesel waste 3Tree-killing fungus officially named by scientists 2American Chemical Society's Weekly PressPac -- June 25, 2008 2American Chemical Society's Weekly PressPac -- June 25, 2008 3American Chemical Society's Weekly PressPac -- June 25, 2008 4American Chemical Society's Weekly PressPac -- June 25, 2008 5American Chemical Society's Weekly PressPac -- June 25, 2008 6American Chemical Society's Weekly PressPac -- June 25, 2008 7American Chemical Society's Weekly PressPac -- June 25, 2008 8American Chemical Society's Weekly PressPac -- June 25, 2008 9